Zinc in PDB 5sfy: Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine
Enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine
All present enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine:
3.1.4.17;
Protein crystallography data
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine, PDB code: 5sfy
was solved by
C.Joseph,
A.Flohr,
J.Benz,
D.Schlatter,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.47 /
2.08
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
135.137,
135.137,
234.83,
90,
90,
120
|
R / Rfree (%)
|
18.2 /
22.5
|
Other elements in 5sfy:
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine
(pdb code 5sfy). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 8 binding sites of Zinc where determined in the
Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine, PDB code: 5sfy:
Jump to Zinc binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
Zinc binding site 1 out
of 8 in 5sfy
Go back to
Zinc Binding Sites List in 5sfy
Zinc binding site 1 out
of 8 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn801
b:31.5
occ:1.00
|
O
|
A:HOH966
|
2.1
|
28.9
|
1.0
|
OD2
|
A:ASP564
|
2.1
|
28.5
|
1.0
|
NE2
|
A:HIS529
|
2.1
|
26.1
|
1.0
|
NE2
|
A:HIS563
|
2.2
|
27.4
|
1.0
|
OD1
|
A:ASP674
|
2.2
|
31.3
|
1.0
|
O
|
A:HOH974
|
2.2
|
33.1
|
1.0
|
CD2
|
A:HIS563
|
3.0
|
25.6
|
1.0
|
CD2
|
A:HIS529
|
3.1
|
25.4
|
1.0
|
CG
|
A:ASP564
|
3.1
|
26.9
|
1.0
|
CE1
|
A:HIS529
|
3.1
|
26.7
|
1.0
|
CG
|
A:ASP674
|
3.1
|
30.9
|
1.0
|
CE1
|
A:HIS563
|
3.2
|
26.8
|
1.0
|
OD2
|
A:ASP674
|
3.4
|
37.0
|
1.0
|
OD1
|
A:ASP564
|
3.5
|
26.2
|
1.0
|
MG
|
A:MG802
|
3.8
|
29.3
|
1.0
|
ZN
|
A:ZN804
|
4.0
|
49.9
|
0.5
|
O
|
A:HOH990
|
4.0
|
27.4
|
1.0
|
CD2
|
A:HIS525
|
4.1
|
29.1
|
1.0
|
CG
|
A:HIS563
|
4.2
|
26.5
|
1.0
|
ND1
|
A:HIS529
|
4.2
|
24.2
|
1.0
|
CG
|
A:HIS529
|
4.2
|
24.5
|
1.0
|
ND1
|
A:HIS563
|
4.3
|
27.2
|
1.0
|
CB
|
A:ASP564
|
4.3
|
26.8
|
1.0
|
NE2
|
A:HIS525
|
4.5
|
31.8
|
1.0
|
CB
|
A:ASP674
|
4.5
|
26.8
|
1.0
|
O
|
A:HOH976
|
4.5
|
42.9
|
1.0
|
O
|
A:HOH911
|
4.6
|
24.0
|
1.0
|
CG2
|
A:VAL533
|
4.7
|
22.2
|
1.0
|
CA
|
A:ASP674
|
4.9
|
26.1
|
1.0
|
O
|
A:ASP674
|
5.0
|
27.1
|
1.0
|
|
Zinc binding site 2 out
of 8 in 5sfy
Go back to
Zinc Binding Sites List in 5sfy
Zinc binding site 2 out
of 8 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn804
b:49.9
occ:0.50
|
NE2
|
A:HIS525
|
2.1
|
31.8
|
1.0
|
O
|
A:HOH974
|
2.1
|
33.1
|
1.0
|
O
|
A:HOH990
|
2.2
|
27.4
|
1.0
|
CE1
|
A:HIS525
|
3.0
|
26.8
|
1.0
|
O
|
A:HOH1002
|
3.0
|
43.6
|
1.0
|
CD2
|
A:HIS525
|
3.1
|
29.1
|
1.0
|
O
|
A:HOH966
|
3.4
|
28.9
|
1.0
|
MG
|
A:MG802
|
3.9
|
29.3
|
1.0
|
O
|
A:HOH976
|
3.9
|
42.9
|
1.0
|
ZN
|
A:ZN801
|
4.0
|
31.5
|
1.0
|
O
|
A:HOH958
|
4.1
|
31.9
|
1.0
|
ND1
|
A:HIS525
|
4.1
|
27.1
|
1.0
|
CG
|
A:HIS525
|
4.2
|
29.5
|
1.0
|
O
|
A:HOH923
|
4.3
|
23.6
|
1.0
|
OD2
|
A:ASP564
|
4.4
|
28.5
|
1.0
|
CE2
|
A:TYR524
|
4.6
|
31.0
|
1.0
|
OD2
|
A:ASP674
|
4.7
|
37.0
|
1.0
|
OD1
|
A:ASP674
|
4.8
|
31.3
|
1.0
|
OD1
|
A:ASP564
|
4.9
|
26.2
|
1.0
|
O
|
A:HOH935
|
5.0
|
33.8
|
1.0
|
NE2
|
A:HIS567
|
5.0
|
29.7
|
1.0
|
|
Zinc binding site 3 out
of 8 in 5sfy
Go back to
Zinc Binding Sites List in 5sfy
Zinc binding site 3 out
of 8 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn801
b:30.6
occ:1.00
|
NE2
|
B:HIS563
|
2.1
|
24.4
|
1.0
|
NE2
|
B:HIS529
|
2.2
|
22.4
|
1.0
|
OD1
|
B:ASP674
|
2.2
|
32.8
|
1.0
|
OD2
|
B:ASP564
|
2.2
|
28.6
|
1.0
|
O
|
B:HOH939
|
2.2
|
19.7
|
1.0
|
CD2
|
B:HIS529
|
3.0
|
25.0
|
1.0
|
CG
|
B:ASP674
|
3.1
|
30.0
|
1.0
|
CD2
|
B:HIS563
|
3.1
|
23.6
|
1.0
|
CE1
|
B:HIS563
|
3.1
|
23.5
|
1.0
|
CG
|
B:ASP564
|
3.2
|
26.2
|
1.0
|
CE1
|
B:HIS529
|
3.3
|
24.8
|
1.0
|
OD2
|
B:ASP674
|
3.3
|
32.7
|
1.0
|
OD1
|
B:ASP564
|
3.7
|
26.4
|
1.0
|
ZN
|
B:ZN804
|
3.7
|
50.2
|
0.5
|
MG
|
B:MG802
|
3.9
|
27.4
|
1.0
|
O
|
B:HOH993
|
3.9
|
27.6
|
1.0
|
CD2
|
B:HIS525
|
4.1
|
23.2
|
1.0
|
ND1
|
B:HIS563
|
4.2
|
23.7
|
1.0
|
CG
|
B:HIS563
|
4.2
|
23.7
|
1.0
|
CG
|
B:HIS529
|
4.2
|
25.0
|
1.0
|
O
|
B:HOH943
|
4.3
|
40.2
|
1.0
|
ND1
|
B:HIS529
|
4.3
|
22.9
|
1.0
|
O
|
B:HOH995
|
4.4
|
39.3
|
1.0
|
CB
|
B:ASP564
|
4.4
|
25.0
|
1.0
|
CB
|
B:ASP674
|
4.5
|
26.5
|
1.0
|
NE2
|
B:HIS525
|
4.5
|
24.4
|
1.0
|
O
|
B:HOH929
|
4.6
|
26.8
|
1.0
|
CG2
|
B:VAL533
|
4.6
|
20.2
|
1.0
|
CA
|
B:ASP674
|
4.9
|
23.7
|
1.0
|
O
|
B:ASP674
|
4.9
|
25.4
|
1.0
|
|
Zinc binding site 4 out
of 8 in 5sfy
Go back to
Zinc Binding Sites List in 5sfy
Zinc binding site 4 out
of 8 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn804
b:50.2
occ:0.50
|
O
|
B:HOH993
|
2.2
|
27.6
|
1.0
|
NE2
|
B:HIS525
|
2.2
|
24.4
|
1.0
|
O
|
B:HOH995
|
2.3
|
39.3
|
1.0
|
CD2
|
B:HIS525
|
3.1
|
23.2
|
1.0
|
O
|
B:HOH1007
|
3.1
|
42.0
|
1.0
|
CE1
|
B:HIS525
|
3.2
|
23.2
|
1.0
|
O
|
B:HOH939
|
3.3
|
19.7
|
1.0
|
O
|
B:HOH943
|
3.7
|
40.2
|
1.0
|
ZN
|
B:ZN801
|
3.7
|
30.6
|
1.0
|
MG
|
B:MG802
|
4.0
|
27.4
|
1.0
|
O
|
B:HOH949
|
4.2
|
25.9
|
1.0
|
OD2
|
B:ASP674
|
4.3
|
32.7
|
1.0
|
CG
|
B:HIS525
|
4.3
|
22.4
|
1.0
|
ND1
|
B:HIS525
|
4.3
|
24.7
|
1.0
|
OD2
|
B:ASP564
|
4.4
|
28.6
|
1.0
|
O
|
B:HOH903
|
4.4
|
22.3
|
1.0
|
OD1
|
B:ASP674
|
4.4
|
32.8
|
1.0
|
CE2
|
B:TYR524
|
4.5
|
33.3
|
1.0
|
NE2
|
B:HIS529
|
4.8
|
22.4
|
1.0
|
CG
|
B:ASP674
|
4.8
|
30.0
|
1.0
|
O
|
B:HOH980
|
4.8
|
34.3
|
1.0
|
OD1
|
B:ASP564
|
4.9
|
26.4
|
1.0
|
|
Zinc binding site 5 out
of 8 in 5sfy
Go back to
Zinc Binding Sites List in 5sfy
Zinc binding site 5 out
of 8 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 5 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn801
b:31.1
occ:1.00
|
O
|
C:HOH940
|
2.1
|
22.2
|
1.0
|
NE2
|
C:HIS529
|
2.1
|
24.8
|
1.0
|
OD1
|
C:ASP674
|
2.2
|
27.3
|
1.0
|
O
|
C:HOH967
|
2.2
|
37.5
|
1.0
|
OD2
|
C:ASP564
|
2.2
|
28.4
|
1.0
|
NE2
|
C:HIS563
|
2.3
|
24.7
|
1.0
|
CG
|
C:ASP674
|
3.1
|
28.4
|
1.0
|
CD2
|
C:HIS529
|
3.1
|
23.9
|
1.0
|
CD2
|
C:HIS563
|
3.1
|
24.0
|
1.0
|
CE1
|
C:HIS529
|
3.2
|
26.5
|
1.0
|
CG
|
C:ASP564
|
3.2
|
26.2
|
1.0
|
OD2
|
C:ASP674
|
3.3
|
31.5
|
1.0
|
CE1
|
C:HIS563
|
3.4
|
23.6
|
1.0
|
OD1
|
C:ASP564
|
3.6
|
27.0
|
1.0
|
MG
|
C:MG802
|
3.7
|
25.3
|
1.0
|
ZN
|
C:ZN804
|
4.0
|
46.4
|
0.5
|
CD2
|
C:HIS525
|
4.0
|
29.7
|
1.0
|
O
|
C:HOH982
|
4.1
|
23.6
|
1.0
|
O
|
C:HOH985
|
4.2
|
38.7
|
1.0
|
ND1
|
C:HIS529
|
4.3
|
24.3
|
1.0
|
CG
|
C:HIS529
|
4.3
|
24.1
|
1.0
|
CG
|
C:HIS563
|
4.3
|
24.9
|
1.0
|
CB
|
C:ASP564
|
4.3
|
24.8
|
1.0
|
NE2
|
C:HIS525
|
4.4
|
30.4
|
1.0
|
ND1
|
C:HIS563
|
4.4
|
26.1
|
1.0
|
CB
|
C:ASP674
|
4.5
|
25.5
|
1.0
|
O
|
C:HOH916
|
4.6
|
22.3
|
1.0
|
CG2
|
C:VAL533
|
4.8
|
22.4
|
1.0
|
CA
|
C:ASP674
|
4.9
|
26.8
|
1.0
|
O
|
C:ASP674
|
4.9
|
26.9
|
1.0
|
|
Zinc binding site 6 out
of 8 in 5sfy
Go back to
Zinc Binding Sites List in 5sfy
Zinc binding site 6 out
of 8 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 6 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn804
b:46.4
occ:0.50
|
O
|
C:HOH967
|
2.1
|
37.5
|
1.0
|
NE2
|
C:HIS525
|
2.1
|
30.4
|
1.0
|
O
|
C:HOH982
|
2.2
|
23.6
|
1.0
|
O
|
C:HOH1001
|
3.0
|
50.2
|
1.0
|
CE1
|
C:HIS525
|
3.1
|
30.2
|
1.0
|
CD2
|
C:HIS525
|
3.1
|
29.7
|
1.0
|
O
|
C:HOH940
|
3.3
|
22.2
|
1.0
|
O
|
C:HOH950
|
3.8
|
32.7
|
1.0
|
O
|
C:HOH985
|
3.8
|
38.7
|
1.0
|
MG
|
C:MG802
|
3.8
|
25.3
|
1.0
|
ZN
|
C:ZN801
|
4.0
|
31.1
|
1.0
|
ND1
|
C:HIS525
|
4.2
|
31.8
|
1.0
|
CG
|
C:HIS525
|
4.2
|
30.6
|
1.0
|
O
|
C:HOH918
|
4.3
|
26.0
|
1.0
|
OD2
|
C:ASP564
|
4.4
|
28.4
|
1.0
|
OD2
|
C:ASP674
|
4.5
|
31.5
|
1.0
|
NE2
|
C:HIS567
|
4.7
|
32.3
|
1.0
|
OD1
|
C:ASP564
|
4.7
|
27.0
|
1.0
|
O
|
C:HOH976
|
4.7
|
34.5
|
1.0
|
OD1
|
C:ASP674
|
4.8
|
27.3
|
1.0
|
O
|
C:HOH981
|
4.8
|
25.7
|
1.0
|
CE2
|
C:TYR524
|
4.8
|
30.3
|
1.0
|
CG
|
C:ASP564
|
5.0
|
26.2
|
1.0
|
|
Zinc binding site 7 out
of 8 in 5sfy
Go back to
Zinc Binding Sites List in 5sfy
Zinc binding site 7 out
of 8 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 7 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn801
b:36.7
occ:1.00
|
O
|
D:HOH931
|
2.0
|
27.4
|
1.0
|
O
|
D:HOH952
|
2.1
|
42.8
|
1.0
|
NE2
|
D:HIS563
|
2.2
|
24.9
|
1.0
|
OD1
|
D:ASP674
|
2.2
|
35.1
|
1.0
|
OD2
|
D:ASP564
|
2.2
|
35.7
|
1.0
|
NE2
|
D:HIS529
|
2.3
|
31.1
|
1.0
|
CD2
|
D:HIS563
|
3.0
|
28.0
|
1.0
|
CG
|
D:ASP674
|
3.1
|
33.2
|
1.0
|
CG
|
D:ASP564
|
3.2
|
33.0
|
1.0
|
CD2
|
D:HIS529
|
3.2
|
34.9
|
1.0
|
OD2
|
D:ASP674
|
3.3
|
37.0
|
1.0
|
CE1
|
D:HIS563
|
3.3
|
29.8
|
1.0
|
CE1
|
D:HIS529
|
3.3
|
30.8
|
1.0
|
OD1
|
D:ASP564
|
3.6
|
32.2
|
1.0
|
MG
|
D:MG802
|
3.8
|
37.8
|
1.0
|
ZN
|
D:ZN804
|
3.9
|
55.6
|
0.5
|
O
|
D:HOH929
|
4.0
|
38.8
|
1.0
|
CD2
|
D:HIS525
|
4.1
|
35.1
|
1.0
|
CG
|
D:HIS563
|
4.2
|
26.8
|
1.0
|
O
|
D:HOH927
|
4.2
|
45.0
|
1.0
|
ND1
|
D:HIS563
|
4.3
|
27.5
|
1.0
|
CB
|
D:ASP564
|
4.4
|
31.5
|
1.0
|
CG
|
D:HIS529
|
4.4
|
33.6
|
1.0
|
ND1
|
D:HIS529
|
4.4
|
31.4
|
1.0
|
CB
|
D:ASP674
|
4.5
|
33.2
|
1.0
|
NE2
|
D:HIS525
|
4.5
|
43.5
|
1.0
|
O
|
D:HOH908
|
4.6
|
32.5
|
1.0
|
CG2
|
D:VAL533
|
4.7
|
32.2
|
1.0
|
O
|
D:ASP674
|
4.8
|
36.0
|
1.0
|
CA
|
D:ASP674
|
4.9
|
32.1
|
1.0
|
|
Zinc binding site 8 out
of 8 in 5sfy
Go back to
Zinc Binding Sites List in 5sfy
Zinc binding site 8 out
of 8 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 8 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 5,8- Dimethyl-2-[(E)-2-[2-Methyl-5-(1H-Pyrazol-4-Yl)-1,2,4-Triazol-3- Yl]Ethenyl]-[1,2,4]Triazolo[1,5-A]Pyrazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn804
b:55.6
occ:0.50
|
O
|
D:HOH952
|
2.0
|
42.8
|
1.0
|
NE2
|
D:HIS525
|
2.1
|
43.5
|
1.0
|
O
|
D:HOH929
|
2.3
|
38.8
|
1.0
|
CE1
|
D:HIS525
|
3.1
|
39.2
|
1.0
|
CD2
|
D:HIS525
|
3.2
|
35.1
|
1.0
|
O
|
D:HOH931
|
3.6
|
27.4
|
1.0
|
O
|
D:HOH970
|
3.6
|
49.4
|
1.0
|
O
|
D:HOH927
|
3.7
|
45.0
|
1.0
|
ZN
|
D:ZN801
|
3.9
|
36.7
|
1.0
|
O
|
D:HOH924
|
4.0
|
42.3
|
1.0
|
MG
|
D:MG802
|
4.0
|
37.8
|
1.0
|
ND1
|
D:HIS525
|
4.2
|
37.0
|
1.0
|
CG
|
D:HIS525
|
4.3
|
35.0
|
1.0
|
O
|
D:HOH911
|
4.4
|
30.5
|
1.0
|
OD2
|
D:ASP564
|
4.5
|
35.7
|
1.0
|
OD2
|
D:ASP674
|
4.6
|
37.0
|
1.0
|
CE2
|
D:TYR524
|
4.6
|
39.0
|
1.0
|
OD1
|
D:ASP674
|
4.7
|
35.1
|
1.0
|
O
|
D:HOH961
|
4.7
|
39.7
|
1.0
|
OD1
|
D:ASP564
|
4.9
|
32.2
|
1.0
|
NE2
|
D:HIS529
|
4.9
|
31.1
|
1.0
|
|
Reference:
A.Tosstorff,
M.G.Rudolph,
J.C.Cole,
M.Reutlinger,
C.Kramer,
H.Schaffhauser,
A.Nilly,
A.Flohr,
B.Kuhn.
A High Quality, Industrial Data Set For Binding Affinity Prediction: Performance Comparison in Different Early Drug Discovery Scenarios. J.Comput.Aided Mol.Des. V. 36 753 2022.
ISSN: ESSN 1573-4951
PubMed: 36153472
DOI: 10.1007/S10822-022-00478-X
Page generated: Mon Oct 28 05:04:36 2024
|